Cravatex FY26 Audited Results Published in Newspapers; Net Profit Rises
Cravatex Limited published its audited standalone and consolidated financial results for FY2025-26 in Business Standard and Sakal on May 16, 2026, per SEBI Regulations 30 and 47. Standalone net profit rose to Rs.555.01 lacs from Rs.486.31 lacs, while consolidated net profit grew to Rs.679.67 lacs from Rs.482.84 lacs. The board recommended a final dividend of Rs.13 per share and scheduled the 74th AGM for July 31, 2026.
*this image is generated using AI for illustrative purposes only.
Cravatex Limited's Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, at their meeting held on Friday, May 15, 2026. In compliance with Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published newspaper advertisements on May 16, 2026, in Business Standard (English) and Sakal (Marathi). The statutory auditors issued an unmodified opinion on the financial results. The full audited financial results, along with the auditors' report, are available on the company's website at www.cravatex.com and on the stock exchange's website at www.bseindia.com .
Standalone Financial Performance
On a standalone basis, Cravatex reported total income of Rs.1,648.18 lacs for FY2025-26, up from Rs.1,432.66 lacs in the previous year. Net profit for the year stood at Rs.555.01 lacs, compared to Rs.486.31 lacs in FY2024-25. The following table presents the key standalone financial metrics:
| Metric (Rupees in Lacs): | Q4 FY2025-26 (Audited) | Q4 FY2024-25 (Audited) | FY2025-26 (Audited) | FY2024-25 (Audited) |
|---|---|---|---|---|
| Revenue from Operations: | - | - | 709.84 | 479.59 |
| Other Income: | 314.36 | 143.99 | 938.34 | 953.07 |
| Total Income: | 314.36 | 143.99 | 1,648.18 | 1,432.66 |
| Total Expenses: | 88.97 | 126.26 | 1,074.30 | 893.61 |
| Profit Before Tax: | 225.39 | 17.73 | 573.88 | 539.05 |
| Total Tax Expense: | 11.62 | 15.96 | 18.87 | 52.74 |
| Net Profit for the Period: | 213.77 | 1.77 | 555.01 | 486.31 |
| Basic EPS (Rs.): | 8.27 | 0.07 | 21.48 | 18.82 |
Consolidated Financial Performance
On a consolidated basis, the group reported total income of Rs.16,769.33 lacs for FY2025-26, compared to Rs.18,371.00 lacs in FY2024-25. Consolidated net profit for the year rose to Rs.679.67 lacs from Rs.482.84 lacs in the prior year. The key consolidated financial metrics are summarised below:
| Metric (Rupees in Lacs): | Q4 FY2025-26 (Audited) | Q4 FY2024-25 (Audited) | FY2025-26 (Audited) | FY2024-25 (Audited) |
|---|---|---|---|---|
| Revenue from Operations: | 3,951.27 | 6,052.12 | 15,087.40 | 17,376.41 |
| Other Income: | 329.54 | 209.23 | 1,681.93 | 994.59 |
| Total Income: | 4,280.81 | 6,261.35 | 16,769.33 | 18,371.00 |
| Total Expenses: | 4,056.62 | 6,050.25 | 15,911.76 | 17,733.80 |
| Profit Before Tax: | 224.19 | 211.10 | 857.57 | 637.20 |
| Total Tax Expenses: | 64.11 | 66.70 | 177.90 | 154.37 |
| Net Profit for the Period: | 160.08 | 144.40 | 679.67 | 482.84 |
| Basic EPS (Rs.): | 6.19 | 5.59 | 26.30 | 18.68 |
Dividend Recommendation and AGM Details
The Board recommended a final dividend of Rs.13 per share on equity shares of Rs.10 each for FY2025-26, subject to shareholder approval. If approved, the dividend will be paid within 30 days from the date of the AGM. The 74th Annual General Meeting is scheduled for Friday, July 31, 2026, via Video Conferencing. The Register of Members and Share Transfer Books will remain closed from Saturday, July 25, 2026 to Friday, July 31, 2026.
Secretarial Auditor Appointment
The board appointed M/s Hemanshu Kapadia & Associates, Practicing Company Secretaries, as Secretarial Auditors for FY2026-27. The firm is led by Mr. Hemanshu Kapadia, a qualified Practicing Company Secretary with approximately three decades of experience.
Historical Stock Returns for Cravatex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.82% | -1.56% | -6.98% | -9.58% | -16.83% | +24.52% |
What strategic initiatives is Cravatex planning to reverse the ~13% decline in consolidated revenue from operations, given the drop from Rs.17,376 lacs to Rs.15,087 lacs in FY2025-26?
How sustainable is Cravatex's growing reliance on 'Other Income' at the standalone level, where it constitutes over 56% of total income, and what does this signal about the core business trajectory?
With the dividend payout increasing to Rs.13 per share, how will Cravatex balance shareholder returns against potential reinvestment needs to revive operational revenue growth?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
